GeoVax Revenue and Competitors
Estimated Revenue & Valuation
- GeoVax's estimated annual revenue is currently $2.5M per year.
- GeoVax's estimated revenue per employee is $77,500
- GeoVax's total funding is $28M.
Employee Data
- GeoVax has 32 Employees.
- GeoVax grew their employee count by 33% last year.
GeoVax's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | VP, Quality Systems and Compliance | Reveal Email/Phone |
3 | VP, Business Development | Reveal Email/Phone |
4 | VP, Head Quality | Reveal Email/Phone |
5 | Head Commercial Development & Operations | Reveal Email/Phone |
6 | Director Vector Development | Reveal Email/Phone |
7 | Executive Medical Director, Oncology | Reveal Email/Phone |
8 | Director, Clinical Operations | Reveal Email/Phone |
9 | Director, Vaccine Development | Reveal Email/Phone |
10 | Director, Project Management | Biotech | Reveal Email/Phone |
GeoVax Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 5 | 0% | N/A | N/A |
#2 | $1.7M | 11 | -8% | N/A | N/A |
#3 | $2.3M | 16 | 14% | N/A | N/A |
#4 | $1.1M | 6 | 0% | N/A | N/A |
#5 | $17.1M | 110 | 5% | $0.07B | N/A |
#6 | $4M | 20 | -5% | N/A | N/A |
#7 | $0.8M | 4 | 0% | N/A | N/A |
#8 | N/A | 866 | 4% | N/A | N/A |
#9 | $1.1M | 5 | -17% | N/A | N/A |
#10 | $7.8M | 42 | 2% | N/A | N/A |
What Is GeoVax?
GeoVax is a Biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus - AIDS) and other infectious agents. Our goals include: developing AIDS vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA guidelines), conducting phase I/II and III human trials for vaccine safety and effectiveness and obtaining regulatory approval of these vaccines in the USA and specified international markets. Outstanding preclinical results: GeoVax DNA/MVA vaccine protected 96% of non-human primates for over 3½ yrs. To our knowledge, this level of protection has not been achieved by other candidate vaccines.
keywords:Biotechnology
$28M
Total Funding
32
Number of Employees
$2.5M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GeoVax News
GeoVax Labs, a biotechnology company focused on the development of vaccines and immunotherapies, announced on April 26, 2022 that the US...
GeoVax Labs, a biotechnology company focused on the development of vaccines and immunotherapies, announced on April 26, 2022 that the US...
GeoVax's Unique Multi-Antigenic Vaccine Approach Designed to Provide Stronger, Broader Protection Against Malaria Atlanta, GA, April 26,...
Other Companies in Smyrna
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.9M | 32 | 23% | N/A |
#2 | $6.9M | 33 | 32% | N/A |
#3 | N/A | 33 | 0% | N/A |
#4 | $11.6M | 34 | 3% | N/A |
#5 | $11.4M | 34 | 6% | N/A |